EdgarLookup

Atea Pharmaceuticals, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Duncan Barbara Gayle Option Exercise 29,600 62,750 Jun 20, 2025
Adams Jerome M. Option Exercise 29,600 62,750 Jun 20, 2025
Murphy Polly A. Option Exercise 29,600 86,045 Jun 20, 2025
BERGER FRANKLIN M Option Exercise 29,600 506,497 Jun 20, 2025
Polsky Bruce Option Exercise 29,600 95,206 Jun 20, 2025
Lucidi Bruno Option Exercise 29,600 112,750 Jun 20, 2025
Vavricka John Chief Commercial Officer Tax Withholding 11,517 $3.06 $35,242 52,081 Jan 31, 2025
Hammond Janet MJ Chief Development Officer Award / Grant 11,250 95,522 Jan 31, 2025
Horga Maria Arantxa Chief Medical Officer Option Exercise 41,533 67,197 Jan 31, 2025
Corcoran Andrea See Remarks Option Exercise 44,367 722,909 Jan 31, 2025
Sommadossi Jean-Pierre President, CEO, and Chairman Tax Withholding 88,601 $3.06 $271,119 300,940 Jan 31, 2025
Foster Wayne EVP, Chief Accounting Officer Tax Withholding 12,062 $3.06 $36,910 50,128 Jan 31, 2025
BERGER FRANKLIN M Purchase 10,000 $3.36 $33,600 476,897 Jan 15, 2025
BERGER FRANKLIN M Purchase 10,000 $3.36 $33,600 476,897 Jan 15, 2025
BERGER FRANKLIN M Sale 359,606 $2.85 $1,024,877 451,897 Dec 10, 2024
Sommadossi Jean-Pierre President, CEO, and Chairman Sale 1,841 $4.00 $7,364 5,866,025 Sep 18, 2024
Polsky Bruce Sale 17,544 $3.49 $61,229 65,606 Jun 20, 2024
Murphy Polly A. Option Exercise 33,150 56,445 Jun 16, 2024
Polsky Bruce Option Exercise 33,150 83,150 Jun 16, 2024
Lucidi Bruno Option Exercise 33,150 83,150 Jun 16, 2024
BERGER FRANKLIN M Option Exercise 33,150 811,503 Jun 16, 2024
Duncan Barbara Gayle Option Exercise 33,150 33,150 Jun 16, 2024
Adams Jerome M. Option Exercise 33,150 33,150 Jun 16, 2024
Sommadossi Jean-Pierre President, CEO, and Chairman Sale 1,006 $4.00 $4,024 5,923,994 Jun 5, 2024
Corcoran Andrea See Remarks Option Exercise 44,367 686,051 Feb 1, 2024
Horga Maria Arantxa Chief Medical Officer Option Exercise 41,534 41,534 Feb 1, 2024
Foster Wayne EVP, Chief Accounting Officer Option Exercise 33,334 33,334 Feb 1, 2024
Vavricka John Chief Commercial Officer Option Exercise 33,334 33,334 Feb 1, 2024
Hammond Janet MJ Chief Development Officer Option Exercise 46,800 49,391 Feb 1, 2024
Sommadossi Jean-Pierre President, CEO, and Chairman Sale 56,910 $3.85 $219,104 116,557 Jan 31, 2024
BERGER FRANKLIN M Sale 16,166 $5.16 $83,417 778,353 Nov 11, 2022
Murphy Polly A. Purchase 12,000 $8.57 $102,840 23,295 Dec 20, 2021
Cormorant Asset Management, LP C 6,411,355 6,411,355 Nov 3, 2020
Rock Springs Capital Master Fund LP C 1,412,016 1,412,016 Nov 3, 2020
Hack Andrew A. F. C 5,365,659 5,365,659 Nov 3, 2020
Murphy Polly A. C 11,295 11,295 Nov 3, 2020
BERGER FRANKLIN M Purchase 41,666 $24.00 $999,984 820,019 Nov 3, 2020
Corcoran Andrea See Remarks C 133,004 633,004 Nov 3, 2020
Sommadossi Jean-Pierre President, CEO, and Chairman C 750,000 5,925,000 Nov 3, 2020
Chu Chung K. C 176,862 1,176,862 Nov 3, 2020
Vavricka John Chief Commercial Officer C 82,508 82,508 Nov 3, 2020